Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
US10653771B2 · kind B2 · utility
0Cited by
49References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2018 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | Jan 3, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16634
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.